Arbutus Biopharma Corporation
Operating companyHQ: United States
Arbutus Biopharma Corporation has been party to twelve Unified Patent Court cases, 10 times as claimant and twice as respondent. The most recent on record is UPC CFI 2562/2026 at The Hague Local Division, against Pfizer Inc.
- 2026-07-16UPC CFI 2562/2026The Hague LD—Genevant Sciences GmbH v Pfizer Inc.
- 2026-07-16UPC CFI 2566/2026The Hague LD—Genevant Sciences GmbH v Pfizer Inc.
- 2025-07-09UPC CFI 617/2025The Hague LD—Moderna Germany GmbH v Arbutus Biopharma Corporation
- 2025-07-08UPC CFI 607/2025The Hague LD—Moderna Italy S.R.L. v Arbutus Biopharma Corporation
- 2025-03-03UPC CFI 191/2025The Hague LDWithdrawnGenevant Sciences GmbH v Moderna Netherlands B.V.
- 2025-03-03UPC CFI 192/2025The Hague LDWithdrawnGenevant Sciences GmbH v Moderna, Inc.
- —UPC APP 18039/2025The Hague LDProcedural onlyArbutus Biopharma Corporation v Moderna Belgium S.R.L.
- —UPC APP 19773/2025The Hague LDProcedural onlyGenevant Sciences GmbH v Moderna Italy S.R.L.
- —UPC APP 25212/2025The Hague LDProcedural onlyGenevant Sciences GmbH v Moderna, Inc.
- —UPC APP 27016/2025The Hague LDProcedural onlyArbutus Biopharma Corporation v Moderna, Inc.